Pathogenesis of respiratory infections and host defenses

Current Opinion in Pulmonary Medicine

Volumn 2, Issue 3, 1996, Pages 166-173

  Zeiher, Bernhardt G ^a   Hornick, Douglas B ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

BACTERIAL INFECTION; BACTERIAL PNEUMONIA; CYSTIC FIBROSIS; EPITHELIUM; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOLOGY; LOBAR PNEUMONIA; MICROBIOLOGY; MUCOCILIARY CLEARANCE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION; REVIEW; SECRETION; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL INFECTIONS; CYSTIC FIBROSIS; CYTOKINES; EPITHELIUM; HUMANS; MUCOCILIARY CLEARANCE; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0030132965     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199605000-00002     Document Type: Article

References (60)

1. Widdecombe JG: Reflexes from the upper respiratory tract. In Handbook of Physiology: The Respiratory System, vol. II. Edited by Fishman AP, Cherniack NS, Widdicombe JG. Bethesda, MD; American Physiological Society; 1986:363-394.
2. Fernandez-Sola J, Junque A, Estruch R, Monforte R, Torres A, Urbano-Marquez A: High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch Intern Med 1995, 155:1649-1654. High alcohol consumption (over 80 g/d for women and over 100 g/d for men 2 years prior to admission) was identified as a major risk factor for developing CAP and conferred a worse prognosis in this case-control study. Other studies have identified the negative aspects of excessive alcohol intake, but the case-control construct of this study isolated the effect of alcohol from comorbid factors such as malnutrition, cirrhosis, chronic obstructive pulmonary disease, smoking, age, diabetes mellitus, and heart failure.
3. Valles J, Artigas A, Rello J, Bonsoms N, Fontanals D, Blanch L, Fernandez R, Baigorri F, Mestre J: Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995, 122:179-186. A device continuously aspirating subglottic secretions was tested in this randomized, controlled, blinded study. The device was shown to reduce the incidence of pneumonia in mechanically ventilated patients who were managed in a medical-surgical intensive care setting.
4. Lister P, Gentry M, Preheim L: Granulocyte colony-stimulating factor protects control rats but not ethanol-fed rats from fatal pneumococcal pneumonia. J Infect Dis 1993, 168:922-926.
5. Nelson S, Summer W, Bagby G, Nakamura C, Stewart L, Lipscomb G, Andresen J: Granulocyte colony-stimulating factor enhances pulmonary host defenses In normal and ethanol-treated rats. J Infect Dis 1991, 164:901-906.
6. Levine SA, Niederman MS: The impact of tracheal intubation on host defense and risks for nosocomial pneumonia. Clin Chest Med 1991, 12:523-543.
7. Johanson WG, Pierce AK, Sanford JP: Changing pharyngeal flora of hospitalized patients: emergence of gram-negative bacilli. N Engl J Med 1969, 281:1137-1140.
8. Johanson WG, Pierce AK, Sanford JP, Thomas GD: Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Int Med 1972, 77:701-706.
9. Horan T, Culver D, Jarvis W, Emori G, Banerjee S, Martone W, Thornsberry C: Pathogens causing nosocomial infections: preliminary data from the National Nosocomial Infections Surveillance System. Antimicrob Newslet 1988, 9:65-67.
10. Schwartz SN, Dowling JN, Benkovic C, DeQuittner-Buchanan M, Prostko T, Yee RB: Sources of gram-negative bacilli colonizing the trachea of intubated patients. J Infect Dis 1978, 138:227-231.
11. Niederman MS, Mantovani R, Schoch P, Papas J, Fein AM: Patterns and rotes of tracheobronchial colonization in mechanically ventilated patients: role of nutritional status in colonization of the lower airway by Pseudomonas species. Chest 1989, 95:155-161.
12. Palmer L, Donelan S, Fox G, Bellemore E, Greene W: Gastric flora in chronically mechanically ventilated patients. Am J Respir Crit Care Med 1995, 151:1063-1067.
13. Torres A, Serra-Baliles J, Ros E, Piera C, Puig de la Bellacasa J, Cobos A, Lomena F, Rodriquez-Roisin R: Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med 1992, 116:540-543.
14. Mahul P, Auboyer C, Jospe R, Ros A, Burein C, el Khouri Z, Galliez M, Dumont A, Gandin O: Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis. Intensive Care Med 1992, 18:20-25.
15. Coonrod JD: The role of extracellular bactericidal factors in pulmonary host defense. Semin Respir Infect 1986, 1:116-129.
16. Finkelstein PA, Sciortino CV, McIntosh MA: The role of iron in microbe-host interactions. Rev Infect Dis 1983, 5:S759-S777.
17. Masson PL, Heramans JF, Prignot JJ, Wautere G: Immunohistochemical localization and bacteriostatic properties of an iron-binding protein from bronchial mucus. Thorax 1966, 21:538-544.
18. Ellison R, Giehl T, LaForce F: Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun 1988, 56:2774-2781.
19. Ellison R, Giehl T: Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 1991, 88:1080-1091.
20. Ellison R, Luo Q, Reller L: Iron-binding proteins enhance the activity of cefotaxime against Escherichia coli. J Antimicrob Chemother 1990, 25:479-481.
21. Stephens S, Dolby J, Montreuil J, Spik G: Differences in inhibition of the growth of commensal and enteropathogenic strains of Escherichia coli by lactotransferrin and secretory immunoglobulin A isolated from human milk. Immunology 1980, 41:597-603.
22. Zasloff M: Antibiotic peptides as mediators of innate immunity. Curr Opin Immunol 1992, 4:3-8. A review of the role antibiotic peptides play in host defense for a variety of animals.
23. Jones D, Bevins C: Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 1992, 267:23216-23225.
24. Diamond G, Zasloff M, Eck H, Brasseur M, Maloy W, Bevins C: Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci U S A 1991, 88:3952-3956.
25. Schonwetter B, Stolzenberg E, Zasloff M: Epithelial antibiotics induced at sites of inflammation. Science 1995, 267:1645-1648. This paper describes a defensin produced by the epithelium of the bovine tongue and shows that its production is up-regulated by infection. We suspect that homologues of these compounds are secreted by human respiratory epithelium and that the identification of such compounds may allow for therapeutic exploitation.
26. Levine S: Bronchial epithelial cell-cytokine interactions in airway inflammation. J Invest Med 1995, 43:241-248. An exhaustive and up-to-date review that focuses on bronchial epithelial cells in the role of secreting and responding to multiple cytokines.
27. Massion P, Inoue H, Richman-Eisenstat J, Grunberger D, Jorens P, Housset B, Pittet J, Wiener-Kronish J, Nadel J: Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J Clin Invest 1994, 93:26-32.
28. DiMango E, Zar H, Bryan R, Prince A: Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 1995, 96:2204-2210. These investigators demonstrate that specific P. aeruginosa adhesins recognize a target compound, asialo GM1, overexpressed in CF epithelial cells. Binding of this receptor incites interleukin 8 release. Furthermore, a P. aeruginosa-derived signaling compound, autoinducer, also causes interleukin B release. This study represents the latest installment by a group of investigators who have made significant contributions toward understanding the molecular cross-talk between P. aeruginosa and CF bronchial epithelium.
29. Inoue H, Massion PP, Ueki IF, Grattan KM, Hara M, Dohrman AF, Chan B, Lausier J, Golden JA, Nadel JA: Pseudomonas stimulates interleukin-8 mRNA expression selectively in airway epithelium, in gland ducts, and in recruited neutrophils. Am J Respir Cell Mol Biol 1994, 11:651-663.
30. Ruef C, Jefferson D, Schlegel-Haueter S, Suter S: Regulation of cytokine secretion by cystic fibrosis airway epithelial cells. Eur Respir J 1993, 6:1429-1436.
31. Bonfield T, Konstan M, Burfeind P, Panuska J, Hilliard J, Berger M: Normal bronchial epithelial cells constituitively produce the anti-inflammatory cytokine interleukin-10, which is down regulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995, 13:257-261.
32. Greenberger M, Strieter R, Kunkel S, Danforth J, Goodman R, Standiford T: Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J Immunol 1995, 155:722-729. These investigators describe an interesting paradox in which blocking normal regulatory function of the anti-inflammatory cytokine interleukin-10 increases survival, as it did in their murine model of acute bacterial pneumonia.
33. Standiford T, Strieter R, Lukacs N, Kunkel S: Neutralization of IL-10 increases lethality in endotoxemia. J Immunol 1995, 155:2222-2229.
34. Richman-Eisenstat JBY, Jorens PG, Ueki J, Olesch J, Nadel JA: Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airways disease. Am J Physiol 1993, 264:1413-L418.
35. Suter S, Schaad UB, Tegner H, Ohlsson K, Desgranchamps D, Waldvogel FA: Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against P. aeruginosa. J Infect Dis 1986, 153:902-909.
36. Meyer KC, Lewandoski RJ, Zimmerman JJ, Numley D, Calhoun WJ, Dopico GA: Human neutrophil elastase and elastase/alpha-1-antiprotease complex in cystic fibrosis. Am Rev Respir Dis 1991, 144:580-585.
37. Khan T, Wagener J, Bost T, Martinez J, Accurso F, Riches D: Early pulmortary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995, 151:1075-1082. This study demonstrates that airway inflammation is present in infants even as young as 4 weeks of age and before significant bacterial colonization can be detected. The link between the genetic defect and this exuberant inflammatory response remains to be delineated.
38. Balough K, McCubbin M, Weinberger M, Smits W, Ahrens R, Fick R: The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol 1995, 20:63-70. This study is one of two that confirm that proinflammatory cytokines are elevated in the lungs of patients with CF prior to measurable bacterial colonization.
39. Imundo L, Barasch J, Prince A, Al-Awqati Q: Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc Natl Acad Sci U S A 1995, 92:3019-3023. How the genetic defect in CF leads to chronic infection remains incompletely understood. This in vitro study demonstrates that CF bronchial epithelial cells are undersialylated compared with the same cells rescued by transfection with DNA-encoding cystic fibrosis transmembrane conductance regulator. Undersialylation results in increased numbers of asialo GM1 on the cell surface, a target for P. aeruginosa and S. aureus adherence. This establishes a plausible link between the genetic defect in CF and chronic infection.
40. Saiman L, Prince A: Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic flbrosis epithelial cells. J Clin Invest 1993, 92:1875-1880.
41. 1 80% of predicted). Adverse effects were identified at a dose of 2 mg/kg but not 1 mg/kg when prednisone was given for less than 24 months.
42. 1 60% or more of predicted). No serious side effects were identified.
43. Konstan M, Vargo K, Davis P: Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection. Am Rev Respir Dis 1990, 141:186-192.
44. Beachy EH, Giampapa CS, Abraham SN: Bacterial adherence: adhesin receptor-mediated attachment of pathogenic bacteria to mucosal surfaces. Am Rev Respir Dis 1988, 138:S45-S48.
45. Leffler H, Svanborg-Eden C: Host epithelial glycoconjugates and pathogenic bacteria. Am J Respir Cell Mol Biol 1990, 2:409-411.
46. Fiala M: A study of the combined role of viruses, mycoplasmas, and bacteria in adult pneumonias. Am J Med Sci 1969, 257:44-51.
47. Davison VE, Sanford BA: Adherence of S. aureus to influenza A virus-infected MDCK cell cultures. Infect Immun 1981, 32:118-126.
48. Sanford BA, Davison VE, Ramsay MA: Fibrinogen-mediated adherence of group A streptococcus to influenza A virus-infected cell cultures. Infect Immun 1982, 38:513-520.
49. Hakansson A, Kidd A, Wadell G, Sabharwal H, Svanborg C: Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae. Infect Immun 1994, 62:2707-2714.
50. Woods DE, Straus DC, Johanson WG, Bass JA: Role of salivary protease activity in adherence of gram-negative bacilli to mammalian buccal epithelial cells in vivo. J Clin Invest 1981, 68:1435-1440.
51. Weinmeister K, DalNogare A: Buccal cell carbohydrates are altered during critical illness. Am J Respir Crit Care Med 1994, 150:131-134.
52. Tuomanen E, Austrian R, Masure H: Pathogenesis of pneumococcal infection. N Engl J Med 1995, 332:1280-1284. The laboratories of Tuomanen and Masure have recently contributed extensively to the molecular aspects of the pathogenesis of pneumococcal pneumonia. Austrian brings the insight of a long-term investigator in the field. Together these authors review the latest molecular details unfolding in the research into S. Pneumoniae interactions with host cells. They describe these recent developments in terms of how they relate to the generation of the classic symptoms and signs of pneumococcal pneumonia. The result is an excellent perspective of the pathogenesis of pneumococcal pneumonia and what the research data indicate for future therapeutic approaches.
53. Austrian R: Some aspects of pneumococcal carrier state. J Antimicrob Chemother 1986, 18:35-45.
54. Cundell D, Weiser J, Shen J, Young A, Tuomanen E: Relationship between colonial morphology and adherence of Streptococcus pneumonias. Infect Immun 1995, 63:757-761.
55. Weiser J, Austrian R, Sreenivasan P, Masure H: Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 1994, 62:2582-2589.
56. Cundell D, Gerard N, Gerard C, Idanpaan-Heikkila I, Tuomanen E: Streptococcus pneumonias anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995, 377:435-438. This study demonstrates that a ligand in the cell wall of S. pneumoniae binds specifically to PAF-R, which is probably the most important step toward the development of invasive disease at the cellular level. Furthermore, these investigators show that blocking this step can reduce the incidence of bacteremia in an animal model. Such work illustrates again that bacterial address-recognition on the surface of epithelial cells is not an isolated, benign event, but in fact can be the initiation event of a well-developed mechanism to subvert the host's natural defense system and set off an array of bacteria-host responses.
57. Tsang K, Rutman A, Tanaka E, Lund V, Dewar A, Cole P, Wilson R: Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro. Eur Respir J 1994, 7:1746-1753.
58. Apodaca G, Bomsel M, Lindstedt R, Engel J, Frank D, Mostov K, Wiener-Kronish J: Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing. Infect Immun 1995, 63:1541-1551. Many other studies have focused mostly on the means of attachment to epithelium by P. aeruginosa. In contrast, this study examines in detail the cellular consequences of P. aeruginosa attachment. The authors show that P. aeruginosa attachment leads to a specific pattern of destruction of the barrier function of the epithelium.
59. Hornick DB, Thommandru J, Smits W, Clegg S: Adherence properties of an mrkD-negative mutant of Klebsiella pneumonias. Infect Immun 1995, 63:2026-2030.
60. Plotkowski MC, Chevillard M, Pierrot D, Altemayer D, Zahm JM, Colliot G, Puchelle E: Differential adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells in primary culture. J Clin Invest 1991, 87:2018-2028.